Top Abstract Purchase Related
Home
>
Node
>
Subnode

Changes in interferon and thymus factor levels as well as in lymphocyte populations in patients with mammary carcinoma

Busse, E.; Rose, H.; Helmholz, M.; Kaiser, E.; Reissbeck, K.H.

Zentralblatt für Gynakologie 103(12): 694-702

1981

ISSN/ISBN: 0044-4197
PMID: 6169232
Document Number: 177275
Changes in interferon and thymus factor as well as in cAMP levels and lymphocyte populations were recorded from patients with mammary carcinoma. They were equally recordable from those in whom no clinical tumour had been detectable at the time of postsurgical examinations as well as from patients with metastases distant from the primary tumour. The possibility for centralised disorder of immunological tumour cell defence in carcinoma patients is discussed.

Document emailed within 1 workday
Secure & encrypted payments

Hayward, A.R.; Ezer, G. 1974: Development of lymphocyte populations in the human foetal thymus and spleen Clinical and Experimental Immunology 17(1): 169-178
Resta, L.; Troia, M.; Russo, S.; Colucci, G.A.; Sabatini, R.; Loiudice, L.; Cagnazzo, G. 1992: Variations of lymphocyte sub-populations in vulvar condylomata during therapy with beta-interferon European Journal of Gynaecological Oncology 13(5): 440-444
Kelso, A.; Glasebrook, A.L. 1984: Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones Journal of Immunology 132(6): 2924-2931
Pozsonyi, T.; Fehér, J.; Jakab, L. 1981: Lymphocyte populations in chronic active liver disease: in vitro effect of levamisole on T-lymphocyte populations Allergologia et Immunopathologia 9(1): 37-44
Matushevskaia, E.V.; Koval'chuk, L.V.; Skriabina, E.G.; Svirezheva, M.N. 1986: Quantitative indices of the lymphocyte populations and of the T gamma lymphocyte subpopulation in the peripheral blood of patients with atopic dermatitis Vestnik Dermatologii i Venerologii 8: 10-12
Kountouras, J.; Boura, P.; Tsapas, G. 1998: In vivo effect of granulocyte-macrophage colony-stimulating factor and interferon combination on monocyte-macrophage and T-lymphocyte functions in chronic hepatitis B leukocytopenic patients Hepato-Gastroenterology 45(24): 2295-2302
Ficek, W. 1983: Physiological dependency between the hypothalamus and the thymus in Wistar rats. III. Hypothalamic cells cultured in vitro in the presence of Thymus Factor X (TFX) and fresh thymus filtered homogenate Gegenbaurs Morphologisches Jahrbuch 129(1): 112-119
Allione, A.; Consalvo, M.; Nanni, P.; Lollini, P.L.; Cavallo, F.; Giovarelli, M.; Forni, M.; Gulino, A.; Colombo, M.P.; Dellabona, P. 1994: Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants Cancer Research 54(23): 6022-6026
Parrott, D.M.; De Sousa, M. 1971: Thymus-dependent and thymus-independent populations: origin, migratory patterns and lifespan Clinical and Experimental Immunology 8(5): 663-684
Chakravarti, A.; Kumaria, R. 2006: Circulating levels of tumour necrosis factor-alpha and interferon-gamma in patients with dengue and dengue haemorrhagic fever during an outbreak Indian Journal of Medical Research 123(1): 25-30
Jirtle, R.L.; Haag, J.D.; Ariazi, E.A.; Gould, M.N. 1993: Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor beta 1 levels during monoterpene-induced regression of mammary tumors Cancer Research 53(17): 3849-3852
Piantelli, M.; Musiani, P.; Lauriola, L.; Carbone, A.; Tonali, P.; Dina, M.A. 1980: Lymphocyte subpopulations in non-neoplastic thymus from myasthenia gravis patients Clinical and Experimental Immunology 41(1): 19-24
Lee, M.Y.; Rosse, C. 1982: Depletion of lymphocyte subpopulations in primary and secondary lymphoid organs of mice by a transplanted granulocytosis-inducing mammary carcinoma Cancer Research 42(4): 1255-1260
Reddy, M.M.; Sorrell, S.J.; Lange, M.; Grieco, M.H. 1988: Tumor necrosis factor and HIV P24 antigen levels in serum of HIV-infected populations Journal of Acquired Immune Deficiency Syndromes 1(5): 436-440
Lagro-Janssen, A.L.M. 2009: Follow-up after mammary carcinoma needs to be longer. Comment to the NHG-standard 'diagnosis of mammary carcinoma' Nederlands Tijdschrift Voor Geneeskunde 153(13): 584-585
Hasek, M.; Karakoz, I.; Kohoutová, L. 1974: Effect of thymus implants and thymus humoral factor on tolerance induction in ducks Folia Biologica 20(6): 427-429
Toker, C. 1976: Time interval to invasive mammary carcinoma in patients with atypical small-cell dysplasia and in situ carcinoma Mount Sinai Journal of Medicine new York 43(1): 53-56
Shi, B.; Nakazawa, H.; Ryoji, O.; Goya, N.; Ito, F.; Koga, S.; Okuda, H.; Kobayashi, H.; Toma, H. 1998: Study on urinary levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in patients with renal cell carcinoma Hinyokika Kiyo. Acta Urologica Japonica 44(3): 143-147
Quartuccio, L.; Mavragani, C.P.; Nezos, A.; Gandolfo, S.; Tzioufas, A.G.; De Vita, S. 2017: Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome Clinical and Experimental Rheumatology 35(4): 719-720
Zatz, M.M.; White, A.; Goldstein, A.L. 1973: Alterations in lymphocyte populations in tumorigenesis. I. Lymphocyte trapping Journal of Immunology 111(3): 706-711